查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
创伤后应激障碍治疗市场规模、份额和趋势分析报告：按药物类别、人口统计数据（成人、儿童）、分销渠道、地区、细分市场预测，2022-2030 年
市场调查报告书
商品编码
1170944

创伤后应激障碍治疗市场规模、份额和趋势分析报告：按药物类别、人口统计数据（成人、儿童）、分销渠道、地区、细分市场预测，2022-2030 年

Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics (Adult, Children), By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

创伤后应激障碍治疗市场的增长和趋势

根据 Grand View Research, Inc. 的一份新报告预测，从 2022 年到 2030 年，全球创伤后应激障碍治疗市场规模的复合年增长率将达到 4.7%，到 2030 年将达到 14 亿美元。 创伤后应激障碍 (PTSD) 的疾病负担不断增加、研发和新药管线的创新以及政府和非营利组织为提高认识所做的努力是推动该领域增长的关键因素。它是

预计在预测期内，用于治疗 PTSD 的有前途的新药管道将为市场增长提供有利可图的机会。 这是由于 Aptinyx 的 NYX-783、Bionomics 的 BNC210 和 Jazz Pharmaceuticals 的 JZP150 正在进行二期临床试验。 此外，Otsuka Pharmaceutical 的 Breexpiprazole 和 Zoloft 联合疗法正处于 3 期试验阶段，各大公司之间为将产品推向该领域的市场展开了激烈的竞争。

COVID-19 大流行等事件进一步推动了该行业的发展。 已经进行了几项研究来了解 COVID-19 大流行对心理健康的影响，增加了 PTSD 的风险并增加了对其治疗的需求。 例如，2021 年 8 月的评论文章“COVID-19 和创伤后应激障碍”。明确指出

公司正在采取战略措施，通过新产品开发、监管审批和地域扩张来帮助扩展其产品组合。 例如，2022 年 3 月，H. Lundbeck A/S 授予 Sun Pharmaceutical Industries Ltd.许可协议，在印度市场以 Vortidiftm 品牌营销和分销 Vortioxetine。

创伤后应激障碍治疗市场报告重点

在 Zoloft（舍曲林）和 Paxil（帕罗西汀）等 FDA 批准的 SSRI 的推动下，预计 2021 年抗抑郁药细分市场将占据最大份额并在预测期内保持其地位

根据人口统计数据，由于老年病发病率上升、老年病患病率高以及外伤经历增加，预测期内復合年增长率为 5.1%，预计将是最快的。

按销售渠道划分，由于长期家庭护理的可用性和适用性等因素，零售药店将在 2021 年主导市场份额。

亚太地区预计在预测期内增长最快，原因是发展中国家的人口意识提高、可支配收入增加以及 PTSD 患病率高

内容

第1章调查方法及范围

  • 市场细分和范围
    • 细分范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库：
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析
      • 方法：产品流方法
  • 调查假设
  • 次要信息列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场前景

第 3 章创伤后应激障碍治疗市场变量、趋势和范围

  • 描绘渗透率和增长前景
  • 用户视角分析
  • 监管和报销框架
  • 市场驱动因素分析
    • PTSD 患病率上升
    • 增加研发以开发新疗法
  • 市场製约因素分析
    • 与药物有关的副作用
  • COVID-19 影响分析
  • SWOT 分析，按因素（政治和法律、经济、技术）
  • 行业分析 - 搬运工

第 4 章。创伤后应激障碍治疗市场：细分分析，按药物类别，2018-2030 年（百万美元）

  • 创伤后应激障碍治疗市场：药物类别的波动分析
  • 抗抑郁药
  • 抗精神病药
  • 抗焦虑
  • 其他

第 5 章创伤后应激障碍治疗市场：细分分析，按人口统计，2018-2030 年（百万美元）

  • 创伤后应激障碍治疗市场：人口变化分析
  • 成人
  • 孩子们

第 6 章创伤后应激障碍治疗市场：细分分析，按分销渠道，2018-2030 年（百万美元）

  • 创伤后应激障碍治疗市场：分销渠道的变化分析
  • 医院药房
  • 零售药房
  • 其他

第 7 章。创伤后应激障碍治疗市场：细分分析，按地区划分，2018-2030 年（百万美元）

  • 定义和范围
  • 2021 年和 2030 年区域市场份额分析
  • 区域市场概况
  • 2021-2030 年市场规模、预测、收入和趋势分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 意大利
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 澳大利亚
      • 韩国
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

第 8 章创伤后应激障碍治疗市场：竞争分析

  • 主要市场进入者的近期趋势和影响分析
    • 新产品发布
    • 併购
    • 伙伴关係和战略协作
    • 会议和活动
  • 公司分类
    • 创新者
    • 市场领导者
    • 热图分析
  • 供应商情况
    • 主要分销商和渠道合作伙伴列表
    • 主要客户
  • 2021 年主要参与者的市场份额分析
  • 上市公司
    • 公司市场分析
    • 竞争仪表板分析
      • 市场差异化因素
  • 私人公司
    • 主要初创企业名单
    • 本地网络地图
  • 公司简介
    • 卢平有限公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 辉瑞公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Aurobindo 製药有限公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 默克集团
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 葛兰素史克公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 大冢製药开发
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 爵士製药
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 生物经济学
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Aptinyx
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 阿斯利康
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-997-2

Post-traumatic Stress Disorder Treatment Market Growth & Trends:

The global post-traumatic stress disorder treatment market size is expected to reach USD 1.4 billion by 2030, registering a CAGR of 4.7% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of post-traumatic stress disorder (PTSD), innovation in R&D and emerging drug pipeline, and efforts by government and non-profit organizations to increase awareness are the key factors augmenting the space growth.

The emerging drug pipeline, thereby, expected advancement and drug launches for the treatment of PTSD, is anticipated to offer a lucrative opportunity for market growth over the forecast period. This can be attributed to the presence of Aptinyx's NYX-783, Bionomics' BNC210, and Jazz Pharmaceuticals' JZP150 under phase 2 clinical trials. Ahead of these, Otsuka Pharmaceutical's Brexpiprazole and Zoloft Combination are in phase 3 trial, creating fierce competition among key players to launch the product in the space.

Events such as the COVID-19 pandemic further support space growth. Several studies have been conducted to understand the impact of the COVID-19 pandemic on mental health, increasing the risk of PTSD and rising demand for its treatment. For instance, the August 2021 review article, "COVID?19 and Post traumatic Stress Disorder: The Perfect 'Storm' for Mental Health," clearly demonstrates an increase in the risk of development of PTSD among pandemic affected families and survivors.

Companies are strategically taking initiatives that aid in developing new products, regulatory approvals, and enhancing their product portfolio with geographical expansion. For instance, in March 2022, H. Lundbeck A/S granted the license agreement to Sun Pharmaceutical Industries Ltd., for marketing and distribute of Vortioxetine under the brand name Vortidiftm in the Indian market.

Post-traumatic Stress Disorder Treatment Market Report Highlights:

  • In 2021, antidepressants segment accounted for the largest share and is anticipated to maintain its position over the forecast period owing to FDA approved SSRIs such as Zoloft (sertraline) and Paxil (paroxetine)
  • Based on demographics, adult segment is estimated to witness the fastest CAGR of 5.1% during the forecast period owing to presence of rising disorder incidence in adult group, major chunk of patients in this age group and increase in traumatic experiences
  • Based on distribution channel, retail pharmacy segment dominated the space in 2021, due to factors such easy of availability, and its compatibility with homecare setting for the long term treatment
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increased awareness among the population, rise in disposable income, and high disease prevalence of PTSD in developing countries

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Post-Traumatic Stress Disorder Treatment Market Variables, Trends, And Scope

  • 3.1 Penetration And Growth Prospect Mapping
  • 3.2 User Perspective Analysis
  • 3.3 Regulatory And Reimbursement Framework
  • 3.4 Market Driver Analysis
    • 3.4.1 Rising Prevalence Of The Ptsd
    • 3.4.2 Increasing R&D For Development Of New Therapies
  • 3.5 Market Restraint Analysis
    • 3.5.1 Side Effects Associated With Drugs
  • 3.6 Covid-19 Impact Analysis
  • 3.7 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.8 Industry Analysis - Porter's

Chapter 4 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Drug Class, 2018 - 2030 (USD Million)

  • 4.1 Post-Traumatic Stress Disorder Treatment Market: Drug Class Movement Analysis
  • 4.2 Antidepressants
    • 4.2.1 Antidepressants Market, 2018 - 2030 (USD Million)
  • 4.3 Antipsychotics
    • 4.3.1 Antipsychotics Market, 2018 - 2030 (USD Million)
  • 4.4 Anti-Anxiety
    • 4.4.1 Anti-Anxiety Market, 2018 - 2030 (USD Million)
  • 4.5 Others
    • 4.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Demographics, 2018 - 2030 (USD Million)

  • 5.1 Post-Traumatic Stress Disorder Treatment Market: Demographics Movement Analysis
  • 5.2 Adult
    • 5.2.1 Adult Market, 2018 - 2030 (USD Million)
  • 5.3 Children
    • 5.3.1 Children Market, 2018 - 2030 (USD Million)

Chapter 6 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Post-Traumatic Stress Disorder Treatment Market: Distribution Channel Movement Analysis
  • 6.2 Hospital Pharmacy
    • 6.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3 Retail Pharmacy
    • 6.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2021 & 2030
  • 7.3 Regional Market Snapshot
  • 7.4 Market Size, & Forecasts, Revenue And Trend Analysis, 2021 to 2030
    • 7.4.1 North America
      • 7.4.1.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.4.1.2 U.S.
      • 7.4.1.2.1 U.S. Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.1.3 Canada
      • 7.4.1.3.1 Canada Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.2 Europe
      • 7.4.2.1 Europe Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.2 U.K.
      • 7.4.2.2.1 Uk Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.3 Germany
      • 7.4.2.3.1 Germany Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.4 France
      • 7.4.2.4.1 France Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.5 Spain
      • 7.4.2.5.1 Spain Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.2.6 Italy
      • 7.4.2.6.1 Italy Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.3 Asia Pacific
      • 7.4.3.1 Asia Pacific Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.2 Japan
      • 7.4.3.2.1 Japan Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.3 China
      • 7.4.3.3.1 China Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.4 India
      • 7.4.3.4.1 India Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.5 Australia
      • 7.4.3.5.1 Australia Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.3.6 South Korea
      • 7.4.3.6.1 South Korea Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.4 Latin America
      • 7.4.4.1 Latin America Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.4.2 Brazil
      • 7.4.4.2.1 Brazil Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.4.3 Mexico
      • 7.4.4.3.1 Mexico Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.4.4 Argentina
      • 7.4.4.4.1 Argentina Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.4.5 Middle East & Africa
      • 7.4.5.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.5.2 South Africa
      • 7.4.5.2.1 South Africa Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.5.3 Saudi Arabia
      • 7.4.5.3.1 Saudi Arabia Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.4.5.4 UAE
      • 7.4.5.4.1 UAE Post-Traumatic Stress Disorder Treatment Market, 2018 - 2030 (USD Million)

Chapter 8 Post-Traumatic Stress Disorder Treatment Market: Competitive Analysis

  • 8.1 Recent Developments And Impact Analysis, By Key Market Participants
    • 8.1.1 New Product Launches
    • 8.1.2 Mergers And Acquisitions
    • 8.1.3 Partnerships And Strategic Collaboration
    • 8.1.4 Conferences And Campaigns
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
    • 8.2.3 Heat Map Analysis
  • 8.3 Vendor Landscape
    • 8.3.1 List Of Key Distributors And Channel Partners
    • 8.3.2 Key Customers
  • 8.4 Key Company Market Share Analysis, 2021
  • 8.5 Public Companies
    • 8.5.1 Company Market Position Analysis
    • 8.5.2 Competitive Dashboard Analysis
      • 8.5.2.1 Market Differentiators
  • 8.6 Private Companies
    • 8.6.1 List Of Key Emerging Companies
    • 8.6.2 Regional Network Map
  • 8.7 Company Profiles
    • 8.7.1 Lupin Limited
      • 8.7.1.1 Company Overview
      • 8.7.1.2 Financial Performance
      • 8.7.1.3 Product Benchmarking
      • 8.7.1.4 Strategic Initiatives
    • 8.7.2 Pfizer, Inc.
      • 8.7.2.1 Company Overview
      • 8.7.2.2 Financial Performance
      • 8.7.2.3 Product Benchmarking
      • 8.7.2.4 Strategic Initiatives
    • 8.7.3 Aurobindo Pharma Limited
      • 8.7.3.1 Company Overview
      • 8.7.3.2 Financial Performance
      • 8.7.3.3 Product Benchmarking
      • 8.7.3.4 Strategic Initiatives
    • 8.7.4 Merck Kgaa
      • 8.7.4.1 Company Overview
      • 8.7.4.2 Financial Performance
      • 8.7.4.3 Product Benchmarking
      • 8.7.4.4 Strategic Initiatives
    • 8.7.5 Glaxosmithkline Plc
      • 8.7.5.1 Company Overview
      • 8.7.5.2 Financial Performance
      • 8.7.5.3 Product Benchmarking
      • 8.7.5.4 Strategic Initiatives
    • 8.7.6 Otsuka Pharmaceutical Development
      • 8.7.6.1 Company Overview
      • 8.7.6.2 Financial Performance
      • 8.7.6.3 Product Benchmarking
      • 8.7.6.4 Strategic Initiatives
    • 8.7.7 Jazz Pharmaceuticals
      • 8.7.7.1 Company Overview
      • 8.7.7.2 Financial Performance
      • 8.7.7.3 Product Benchmarking
      • 8.7.7.4 Strategic Initiatives
    • 8.7.8 Bionomics
      • 8.7.8.1 Company Overview
      • 8.7.8.2 Financial Performance
      • 8.7.8.3 Product Benchmarking
      • 8.7.8.4 Strategic Initiatives
    • 8.7.9 Aptinyx
      • 8.7.9.1 Company Overview
      • 8.7.9.2 Financial Performance
      • 8.7.9.3 Product Benchmarking
      • 8.7.9.4 Strategic Initiatives
    • 8.7.10 Astrazeneca
      • 8.7.10.1 Company Overview
      • 8.7.10.2 Financial Performance
      • 8.7.10.3 Product Benchmarking
      • 8.7.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviation
  • Table 3 List of Key Distributors
  • Table 4 List of Other Companies
  • Table 5 List of Key Emerging Companies/Demographics Disruptors/innovators
  • Table 6 Global Post-traumatic Stress Disorder Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 Global Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8 Global Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 9 Global Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 North America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 North America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 12 North America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 13 North America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 U.S. Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 15 U.S. Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 16 U.S. Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Canada Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 18 Canada Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 19 Canada Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Europe Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 22 Europe Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 23 Europe Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 U.K. Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 U.K. Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 26 U.K. Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 28 Germany Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 29 Germany Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 France Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 31 France Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 32 France Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Spain Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 34 Spain Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 35 Spain Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Italy Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Italy Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 38 Italy Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Japan Post-traumatic Stress Disorder Treatment Market, By Drug Class Type, 2018 - 2030 (USD Million)
  • Table 44 Japan Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 45 Japan Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 China Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 47 China Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 48 China Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 49 India Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 50 India Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 51 India Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 Australia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Australia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 54 Australia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 South Korea Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 56 South Korea Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 57 South Korea Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Latin America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 59 Latin America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 60 Latin America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 61 Latin America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Brazil Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 63 Brazil Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 64 Brazil Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Mexico Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 66 Mexico Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 67 Mexico Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 Argentina Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 69 Argentina Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 70 Argentina Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71 MEA Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 MEA Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 73 MEA Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 74 MEA Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 South Africa Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 76 South Africa Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 77 South Africa Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 81 UAE Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 82 UAE Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 83 UAE Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Post-traumatic stress disorder treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2020)
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 User perspective analysis
  • Fig. 12 Post-traumatic stress disorder treatment market driver impact
  • Fig. 11 Prevalence of PTSD by WHO regions (in 2021)
  • Fig. 12 Post-traumatic stress disorder treatment market restraint impact
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Post-traumatic stress disorder treatment market drug class outlook: Key takeaways
  • Fig. 16 Post-traumatic stress disorder treatment market: Drug class movement analysis
  • Fig. 17 Antidepressants market, 2018 - 2030 (USD million)
  • Fig. 18 Antipsychotics market, 2018 - 2030 (USD million)
  • Fig. 19 Anti-anxiety market, 2018 - 2030 (USD million)
  • Fig. 20 Others market, 2018 - 2030 (USD million)
  • Fig. 21 Post-traumatic stress disorder treatment market demographics outlook: Key takeaways
  • Fig. 22 Post-traumatic stress disorder treatment market: Demographics movement analysis
  • Fig. 23 Adult market, 2018 - 2030 (USD million)
  • Fig. 24 Children market, 2018 - 2030 (USD million)
  • Fig. 25 Post-traumatic stress disorder treatment market distribution channel outlook: Key takeaways
  • Fig. 26 Post-traumatic stress disorder treatment market: Distribution channel movement analysis
  • Fig. 27 Hospital pharmacy market, 2018 - 2030 (USD million)
  • Fig. 28 Retail pharmacy market, 2018 - 2030 (USD million)
  • Fig. 29 Others market, 2018 - 2030 (USD million)
  • Fig. 30 Regional outlook, 2021 & 2030
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America
  • Fig. 33 North America post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S.
  • Fig. 35 U.S. post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada
  • Fig. 37 Canada post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe
  • Fig. 39 Europe post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 U.K.
  • Fig. 41 U.K. post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany
  • Fig. 43 Germany post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 France
  • Fig. 45 France post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain
  • Fig. 47 Spain post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy
  • Fig. 49 Italy post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific
  • Fig. 51 Asia Pacific post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan
  • Fig. 53 Japan post-traumatic stress disorder treatment market et, 2018 - 2030 (USD Million)
  • Fig. 54 China
  • Fig. 55China post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 India
  • Fig. 57 India post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia
  • Fig. 59 Australia post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea
  • Fig. 61 South Korea post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America
  • Fig. 63 Latin America post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil
  • Fig. 65 Brazil post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico
  • Fig. 67 Mexico post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina
  • Fig. 69 Argentina post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East & Africa
  • Fig. 71 Middle East & Africa post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa
  • Fig. 73 South Africa post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia
  • Fig. 75 Saudi Arabia post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE
  • Fig. 77 UAE post-traumatic stress disorder treatment market, 2018 - 2030 (USD Million)
  • Fig. 78 Heat map analysis
  • Fig. 79 Company market share analysis (2021)
  • Fig. 80 Company market position analysis (2021)
  • Fig. 81 Company market position analysis (2021)
  • Fig. 82 Market differentiators
  • Fig. 83 Regional network map